The CSE
So I think we got 2 of our 10 questions somewhat answered. Well, at least he read them. And it was fun coming up with them and part of the Helix adventure. So, even if he didn't get to them all, he at least got to hear our input and concerns.
I think his answer about the CSC, however, is a transcriptionist error. I think what I heard was CSE because that's what I know when I think of the Canadian stock exchange. That's the Canadian Stock Exchange, and I recall Helix mentionining Sedar back then. I mentioned Sedar in my question, so he's skimming and paraphrasing me. Not htat it really matters, but the CSE is for small caps but has minimal capital requirements and higher standards than the small cap Sedar. And at the CSE, I love it because you have to fill out and submit a small Q&A every single month. And their regulation is much more respectable than our OTC. OTC is good, but Sedar is better, and CSE is even better than that in my opinion. As far as regulation and reporting standards go. And I like their format better, such as the MD&A. Not necessarily better liquidity over there.
This is what got transcribed:
We did have a plan to go into the CSC. And essentially we offer that plan just because of the market conditions at that time. So as an example now, given where cannabis capital markets are today if we were looking to list let's say on the OTC, which were already listed on the OTC, but were we to do that today, we would probably say no, we want to wait because we felt that the market conditions were tight and we're going to be a great benefit to the company.
So that same scenario essentially happened back then. There were certain assumptions that we had. That didn't seem - and it didn't seem like the right thing to do at that time was continue with CSC listening.
Now that said, we continue to evaluate all possibilities for increasing our shareholder value and liquidity to include listing on a different exchange sometime in the future or an additional exchange sometime in the future. And we'll make the appropriate announcements when the time comes.
So, there's that. He didn't ever get back to this statement he said in Q1: "And we're already seeing substantially improved offerings of finance that we hope to report positively on in the Q2 call.."
Oh, well. I don't think he reported on that. But at least no rude people on this call. And, I partly blame myself for not pressing that answer, but it's hard enough to work and listen at the same time. Nice of them to put out a transcript within one hour. Very consistent on that. Unlike NROM whose transcript may get shredded or might get posted days later. You never know.
